Company
Health tech company developing CAR-T cell therapy for cancer treatment
Christchurch, OS
Every investor coverage indicates participated in a round BioOra raised.
Companies BioOra acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming BioOra. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of BioOra CEO John Robson covering the cell-therapy company's $15m raise last year, a live round with about $20m committed, a Cincinnati hospital partnership, and Christchurch manufacturing plans.